(Reuters) - Moderna Inc has begun dosing patients in a mid-to-late stage study of its COVID-19 vaccine, mRNA-1273, in children aged six months to less than 12 years, the company said on Tuesday.
There’s reason for optimism on the coronavirus pandemic: The number of new Covid-19 cases is dropping, and 98.2 million doses of coronavirus vaccines have been administered in the United States. But a decline in the number of coronavirus tests being conducted threatens this progress, because those tests are vital to tracing the path and velocity of Covid-19.
The average number of tests being conducted daily to detect the coronavirus in the United States has dropped 20 percent since Feb. 1. At the same time, the nation does not have enough rapid tests to conduct routine testing outside of sites run by local health departments and medical clinics. America needs to expand the nation’s testing capacity and accelerate the proliferation of rapid coronavirus tests in order to overcome Covid-19.
(Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
A massive $1.9 trillion pandemic relief bill now on its way to President Joe Biden’s desk will deliver cash to a wide array of groups—including the scientific community.
The U.S. House of Representatives today approved final passage of the bill, which Biden is expected to sign on Friday, on a 220–211 party-line vote.
The Food and Drug Administration on Friday issued an emergency authorization for a new test to detect Covid-19 infections — one that stands apart from the hundreds already authorized.
